Neoadjuvant chemotherapy in ER+ HER2- breast cancer: Response prediction based on immunohistochemical and molecular characteristics

Breast Cancer Research and Treatment

Volumn 131, Issue 3, 2012, Pages 827-836

  Lips, E H ^a   Mulder, L ^a   De Ronde, J J ^a   Mandjes, I A M ^a   Vincent, A ^a   Vrancken Peeters, M T F D ^a   Nederlof, P M ^a   Wesseling, J ^a   Rodenhuis, S ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

Luminal subtype; Molecular subtypes; Neoadjuvant chemotherapy; Predictive factors

Indexed keywords

CAPECITABINE; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; MESSENGER RNA;

ADULT; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER PROGNOSIS; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HISTOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MOLECULAR DYNAMICS; MULTIPLE CYCLE TREATMENT; MULTIVARIATE ANALYSIS; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; TREATMENT RESPONSE; TUMOR BIOPSY;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; PROGNOSIS; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 84856217284     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-011-1488-0     Document Type: Article

References (36)

1. Early Breast Cancer Trialists' Collaborative Group 2005 Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials Lancet 365 9472 1687 1717 10.1016/S0140-6736(05)66544-0
2. J Bergh M Holmquist 2001 Who should not receive adjuvant chemotherapy? International databases J Natl Cancer Inst Monogr 30 103 108 11773301
3. PM Ravdin LA Siminoff GJ Davis MB Mercer J Hewlett N Gerson HL Parker 2001 Computer program to assist in making decisions about adjuvant therapy for women with early breast cancer J Clin Oncol 19 4 980 991 11181660 1:STN:280:DC%2BD3M3gsFalsg%3D%3D
4. A Katz ED Saad P Porter L Pusztai 2007 Primary systemic chemotherapy of invasive lobular carcinoma of the breast Lancet Oncol 8 1 55 62 17196511 10.1016/S1470-2045(06)71011-7 1:CAS:528:DC%2BD2sXhsFGlsw%3D%3D
5. VF Cocquyt PN Blondeel HT Depypere MM Praet VR Schelfhout OE Silva J Hurley RF Serreyn KK Daems SJ Van Belle 2003 Different responses to preoperative chemotherapy for invasive lobular and invasive ductal breast carcinoma Eur J Surg Oncol 29 4 361 367 12711290 10.1053/ejso.2002.1404 1:STN:280: DC%2BD3s7pt1eisA%3D%3D
6. M Tubiana-Hulin D Stevens S Lasry JM Guinebretiere L Bouita C Cohen-Solal P Cherel J Rouesse 2006 Response to neoadjuvant chemotherapy in lobular and ductal breast carcinomas: a retrospective study on 860 patients from one institution Ann Oncol 17 8 1228 1233 16740599 10.1093/annonc/mdl114 1:STN:280:DC%2BD28vkvVOrsA%3D%3D
7. A Goldhirsch WC Wood RD Gelber AS Coates B Thurlimann HJ Senn 2007 Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007 Ann Oncol 18 7 1133 1144 17675394 10.1093/annonc/mdm271 1:STN:280:DC%2BD2svlvVSkuw%3D%3D
8. T Sorlie R Tibshirani J Parker T Hastie JS Marron A Nobel S Deng H Johnsen R Pesich S Geisler J Demeter CM Perou PE Lonning PO Brown AL Borresen-Dale D Botstein 2003 Repeated observation of breast tumor subtypes in independent gene expression data sets Proc Natl Acad Sci USA 100 14 8418 8423 12829800 10.1073/pnas.0932692100 1:CAS:528:DC%2BD3sXlsFGntLk%3D
9. CM Perou T Sorlie MB Eisen M van de Rijn SS Jeffrey CA Rees JR Pollack DT Ross H Johnsen LA Akslen O Fluge A Pergamenschikov C Williams SX Zhu PE Lonning AL Borresen-Dale PO Brown D Botstein 2000 Molecular portraits of human breast tumours Nature 406 6797 747 752 10963602 10.1038/35021093 1:CAS:528: DC%2BD3cXmt1CnsLw%3D
10. JS Parker M Mullins MC Cheang S Leung D Voduc T Vickery S Davies C Fauron X He Z Hu JF Quackenbush IJ Stijleman J Palazzo JS Marron AB Nobel E Mardis TO Nielsen MJ Ellis CM Perou PS Bernard 2009 Supervised risk predictor of breast cancer based on intrinsic subtypes J Clin Oncol 27 8 1160 1167 19204204 10.1200/JCO.2008.18.1370
11. M Colleoni V Bagnardi N Rotmensz G Viale M Mastropasqua P Veronesi A Cardillo R Torrisi A Luini A Goldhirsch 2010 A nomogram based on the expression of Ki-67, steroid hormone receptors status and number of chemotherapy courses to predict pathological complete remission after preoperative chemotherapy for breast cancer Eur J Cancer 46 12 2216 2224 20471822 10.1016/j.ejca.2010.04.008 1:CAS:528:DC%2BC3cXpsFyisr0%3D
12. ME Straver AM Glas J Hannemann J Wesseling MJ van de Vijver EJ Rutgers MJ Vrancken Peeters H van Tinteren LJ Van't Veer S Rodenhuis 2010 The 70-gene signature as a response predictor for neoadjuvant chemotherapy in breast cancer Breast Cancer Res Treat 119 3 551 558 19214742 10.1007/s10549-009-0333-1
13. S Paik G Tang S Shak C Kim J Baker W Kim M Cronin FL Baehner D Watson J Bryant JP Costantino CE Geyer Jr DL Wickerham N Wolmark 2006 Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer J Clin Oncol 24 23 3726 3734 16720680 10.1200/JCO.2005.04.7985 1:CAS:528:DC%2BD28XpsVaqsrs%3D
14. B Thurlimann KN Price RD Gelber SB Holmberg D Crivellari M Colleoni J Collins JF Forbes M Castiglione-Gertsch AS Coates A Goldhirsch 2009 Is chemotherapy necessary for premenopausal women with lower-risk node-positive, endocrine responsive breast cancer? 10-year update of International Breast Cancer Study Group Trial 11-93 Breast Cancer Res Treat 113 1 137 144 18259856 10.1007/s10549-008-9912-9
15. M Colleoni G Viale A Goldhirsch 2009 Lessons on responsiveness to adjuvant systemic therapies learned from the neoadjuvant setting Breast 18 3 S137 S140 19914533 10.1016/S0960-9776(09)70289-9
16. FM Blows KE Driver MK Schmidt A Broeks FE van Leeuwen J Wesseling MC Cheang K Gelmon TO Nielsen C Blomqvist P Heikkila T Heikkinen H Nevanlinna LA Akslen LR Begin WD Foulkes FJ Couch X Wang V Cafourek JE Olson L Baglietto GG Giles G Severi CA McLean MC Southey E Rakha AR Green IO Ellis ME Sherman J Lissowska WF Anderson A Cox SS Cross MW Reed E Provenzano SJ Dawson AM Dunning M Humphreys DF Easton M Garcia-Closas C Caldas PD Pharoah D Huntsman 2010 Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 cases from 12 studies PLoS Med 7 5 e1000279 20520800 10.1371/journal.pmed.1000279
17. S Rodenhuis IA Mandjes J Wesseling MJ van de Vijver MJ Peeters GS Sonke SC Linn 2010 A simple system for grading the response of breast cancer to neoadjuvant chemotherapy Ann Oncol 21 3 481 487 19717533 10.1093/annonc/mdp348 1:STN:280:DC%2BC3c7isVClsg%3D%3D
18. CE Loo HJ Teertstra S Rodenhuis MJ van de Vijver J Hannemann SH Muller MJ Peeters KG Gilhuijs 2008 Dynamic contrast-enhanced MRI for prediction of breast cancer response to neoadjuvant chemotherapy: initial results AJR Am J Roentgenol 191 5 1331 1338 18941065 10.2214/AJR.07.3567
19. JJ de Ronde J Hannemann H Halfwerk L Mulder ME Straver MJ Vrancken Peeters J Wesseling M van de Vijver LF Wessels S Rodenhuis 2010 Concordance of clinical and molecular breast cancer subtyping in the context of preoperative chemotherapy response Breast Cancer Res Treat 119 1 119 126 19669409 10.1007/s10549-009-0499-6
20. M Colleoni V Bagnardi N Rotmensz RD Gelber G Viale G Pruneri P Veronesi R Torrisi A Cardillo E Montagna E Campagnoli A Luini M Intra V Galimberti E Scarano G Peruzzotti A Goldhirsch 2009 Increasing steroid hormone receptors expression defines breast cancer subtypes non responsive to preoperative chemotherapy Breast Cancer Res Treat 116 2 359 369 18941889 10.1007/s10549-008- 0223-y 1:CAS:528:DC%2BD1MXntF2ntrY%3D
21. J Hannemann HM Oosterkamp CA Bosch A Velds LF Wessels C Loo EJ Rutgers S Rodenhuis MJ van de Vijver 2005 Changes in gene expression associated with response to neoadjuvant chemotherapy in breast cancer J Clin Oncol 23 15 3331 3342 15908647 10.1200/JCO.2005.09.077 1:CAS:528:DC%2BD2MXlsVyiu70%3D
22. VG Tusher R Tibshirani G Chu 2001 Significance analysis of microarrays applied to the ionizing radiation response Proc Natl Acad Sci USA 98 9 5116 5121 11309499 10.1073/pnas.091062498 1:CAS:528:DC%2BD3MXjt1Ons7w%3D
23. NS Goldstein D Decker D Severson S Schell F Vicini J Margolis NS Dekhne 2007 Molecular classification system identifies invasive breast carcinoma patients who are most likely and those who are least likely to achieve a complete pathologic response after neoadjuvant chemotherapy Cancer 110 8 1687 1696 17722109 10.1002/cncr.22981 1:CAS:528:DC%2BD2sXht1GksLzN
24. R Rouzier CM Perou WF Symmans N Ibrahim M Cristofanilli K Anderson KR Hess J Stec M Ayers P Wagner P Morandi C Fan I Rabiul JS Ross GN Hortobagyi L Pusztai 2005 Breast cancer molecular subtypes respond differently to preoperative chemotherapy Clin Cancer Res 11 16 5678 5685 16115903 10.1158/1078-0432.CCR-04-2421 1:CAS:528:DC%2BD2MXos1Cjs7k%3D
25. IF Faneyte JG Schrama JL Peterse PL Remijnse S Rodenhuis MJ van de Vijver 2003 Breast cancer response to neoadjuvant chemotherapy: predictive markers and relation with outcome Br J Cancer 88 3 406 412 12569384 10.1038/sj.bjc.6600749 1:STN:280:DC%2BD3s%2FlvVChtA%3D%3D
26. P Rastogi SJ Anderson HD Bear CE Geyer MS Kahlenberg A Robidoux RG Margolese JL Hoehn VG Vogel SR Dakhil D Tamkus KM King ER Pajon MJ Wright J Robert S Paik EP Mamounas N Wolmark 2008 Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27 J Clin Oncol 26 5 778 785 18258986 10.1200/JCO.2007.15.0235
27. JA van der Hage CJ van de Velde JP Julien M Tubiana-Hulin C Vandervelden L Duchateau 2001 Preoperative chemotherapy in primary operable breast cancer: results from the European Organization for Research and Treatment of Cancer trial 10902 J Clin Oncol 19 22 4224 4237 11709566
28. WF Symmans F Peintinger C Hatzis R Rajan H Kuerer V Valero L Assad A Poniecka B Hennessy M Green AU Buzdar SE Singletary GN Hortobagyi L Pusztai 2007 Measurement of residual breast cancer burden to predict survival after neoadjuvant chemotherapy J Clin Oncol 25 28 4414 4422 17785706 10.1200/JCO.2007.10.6823
29. ME Straver EJ Rutgers S Rodenhuis SC Linn CE Loo J Wesseling NS Russell HS Oldenburg N Antonini MT Vrancken Peeters 2010 The relevance of breast cancer subtypes in the outcome of neoadjuvant chemotherapy Ann Surg Oncol 17 9 2411 2418 20373039 10.1245/s10434-010-1008-1 1:STN:280:DC%2BC3cjmtVCqsQ%3D%3D
30. F Cardoso L Van't Veer E Rutgers S Loi S Mook MJ Piccart-Gebhart 2008 Clinical application of the 70-gene profile: the MINDACT trial J Clin Oncol 26 5 729 735 18258980 10.1200/JCO.2007.14.3222
31. JA Sparano S Paik 2008 Development of the 21-gene assay and its application in clinical practice and clinical trials J Clin Oncol 26 5 721 728 18258979 10.1200/JCO.2007.15.1068
32. H Bonnefoi A Potti M Delorenzi L Mauriac M Campone M Tubiana-Hulin T Petit P Rouanet J Jassem E Blot V Becette P Farmer S Andre CR Acharya S Mukherjee D Cameron J Bergh JR Nevins RD Iggo 2011 Retraction-Validation of gene signatures that predict the response of breast cancer to neoadjuvant chemotherapy: a substudy of the EORTC 10994/BIG 00-01 clinical trial Lancet Oncol 12 2 116 21277543 10.1016/S1470-2045(11)70011-0
33. A Potti HK Dressman A Bild RF Riedel G Chan R Sayer J Cragun H Cottrill MJ Kelley R Petersen D Harpole J Marks A Berchuck GS Ginsburg P Febbo J Lancaster JR Nevins 2011 Retraction: genomic signatures to guide the use of chemotherapeutics Nat Med 17 1 135 21217686 10.1038/nm0111-135 1:CAS:528:DC%2BC3MXjsFaitA%3D%3D
34. P Borst L Wessels 2010 Do predictive signatures really predict response to cancer chemotherapy? Cell Cycle 9 24 4836 4840 21150277 10.4161/cc.9.24.14326 1:CAS:528:DC%2BC3MXitFSltbw%3D
35. V Popovici W Chen BG Gallas C Hatzis W Shi FW Samuelson Y Nikolsky M Tsyganova A Ishkin T Nikolskaya KR Hess V Valero D Booser M Delorenzi GN Hortobagyi L Shi WF Symmans L Pusztai 2010 Effect of training-sample size and classification difficulty on the accuracy of genomic predictors Breast Cancer Res 12 1 R5 20064235 10.1186/bcr2468
36. C Kim S Paik 2010 Gene-expression-based prognostic assays for breast cancer Nat Rev Clin Oncol 7 6 340 347 20440284 10.1038/nrclinonc.2010.61 1:CAS:528:DC%2BC3cXmslGgsLY%3D